Long-term efficacy and safety of repeated botulinum toxin a applications based on function and anesthesia type in children with cerebral palsy
- 1 January 2022
- journal article
- research article
- Published by Elsevier in Journal of Orthopaedics
- Vol. 29, 22-27
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Off Label Use of Botulinum Toxin in Children under Two Years of Age: A Systematic ReviewToxins, 2013
- Therapeutic Use of Botulinum Toxin in NeurorehabilitationJournal of Toxicology, 2011
- Botulinum Toxin Type A Injections for Treatment of Spastic Equinus in Cerebral PalsyAmerican Journal of Physical Medicine & Rehabilitation, 2010
- Botulinum toxin assessment, intervention and follow‐up for paediatric upper limb hypertonicity: international consensus statementEuropean Journal of Neurology, 2010
- The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsyEuropean Journal of Paediatric Neurology, 2010
- Safety of botulinum toxin type A in children younger than 2 yearsEuropean Journal of Paediatric Neurology, 2009
- Long‐term effects of botulinum toxin A in children with cerebral palsyDevelopmental Medicine & Child Neurology, 2009
- Repeat injection of botulinum toxin A is safe and effective for upper limb movement and function in children with cerebral palsyDevelopmental Medicine & Child Neurology, 2007
- Psychological effects of repeated general anesthesia in childrenPediatric Anesthesia, 2006
- The post-anesthesia recovery score revisitedJournal of Clinical Anesthesia, 1995